SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lactose (India) Ltd (524202)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524202 NSE: Pharmaceuticals & Drugs | Small Cap | Lactose India Share Price

₹110.45 -4.20 (-3.66%)

As on 04-Jun'26 16:59

Lactose (India) Ltd (524202)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524202 NSE: Pharmaceuticals & Drugs | Small Cap | Lactose India Share Price

₹110.45 -4.20 (-3.66%)

As on 04-Jun'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹139 Cr.
Current Price
₹110.5
52-Week Low / High
₹76 / 137
TTM EPS
₹4.8
TTM Sales
₹163 Cr.
Book Value per Share
₹51.5
P/E Ratio
22.93
Lower than its 5-year historical median
Industry PE
46.5
Price to Book (P/B)
2.15
In line with its 5-year historical median
Price to Sales (P/S)
0.85
Lower than its 5-year historical median
EV/EBITDA
10.28
In line with its 5-year historical median
Dividend Yield
0.00%
Profitability Efficiency
Return on Equity (ROE)
10.40%
Outperforms industry median
Return on Capital Employed (ROCE)
13.01%
Outperforms industry median
Return on Assets (ROA)
4.41%
Operating Profit Margin
14.5%
Net Profit Margin
4.44%
Gross Profit Margin
10.6%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
2.2%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
-11.12%
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
-24.01%
Asset Quality
Promoter Holding
53.65%
Pledged shares (%) of Promoter's holding (%)
26.07%
Reserves
₹52 Cr.
Equity
₹12.6 Cr.
Face Value
₹10
All Time Low / High
₹0.25 / 247.40

Lactose (India) stock performance

Key Ratios
mw4me loader

Check Before You Invest

Quality

Somewhat Good

Valuation

Undervalued

Price Trend

Weak
Q.1 Is Lactose (India) Ltd a good quality company?
Lactose (India) Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Lactose (India) Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Lactose (India) Ltd vs industry peers?
Lactose (India) Ltd revenue CAGR is 23.79%, compared to the industry median CAGR of 5.35%, indicating faster growth and gaining its market share.
Q.1 Promoter shareholding and pledge status of Lactose (India) Ltd?
Promoters hold 53.65% of the Lactose (India) Ltd, with 26.07% of their stake pledged, indicating high pledge risk.
Q.1 Stock return of Lactose (India) Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 5.3% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Lactose (India) Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 14.8%14.8%4.1%9.1%7.8%2.8%10.2%9.3%18.2%13%-
Value Creation
Index
0.10.1-0.7-0.4-0.4-0.8-0.3-0.30.3-0.1-

Growth Parameters

Sales 34.535.731.140.640.13545.965.8114116163
Sales YoY Gr.-3.5%-12.8%30.6%-1.4%-12.7%31.4%43.2%73.1%2.2%-
Adj EPS 2.52.9-1.30.60.1-2.21.80.95.13.84.8
YoY Gr.-13.4%-146.3%NA-88.7%-3242.9%NA-52.2%487.4%-25.1%-
BVPS (₹) 22.527.631.133.633.730.231.232.237.441.551.5
Adj Net
Profit
2.22.8-1.30.60.1-2.52.31.16.44.86
Cash Flow from Ops. 1.57.60.24.97.42.28.57.98.8-0.3-
Debt/CF from Ops. 25.34.6238.57.45.321.34.94.94.4-192.2-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales 14.5%23.8%36.3%2.2%
Adj EPS 4.7%122.7%28.2%-25.1%
BVPS7.1%4.3%10%10.9%
Share Price 4.6% 29.7% 32.2% 17.5%

Key Financial Parameters

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
12.311.8-4.61.90.2-7.36.22.814.79.110.4
Op. Profit
Mgn %
30.431.918.123.723.217.826.717.316.714.510.9
Net Profit
Mgn %
6.57.8-4.31.60.2-7.251.75.64.23.7
Debt to
Equity
1.91.31.21.11.11.31.110.81.10.4
Working Cap
Days
18720721115817721919920114217379
Cash Conv.
Cycle
425768649112310086579111

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales3436314140354666114116
Operating Expenses + 242425313129345495100
Manufacturing Costs77799910182526
Material Costs7566647245151
Employee Cost 789111211127910
Other Costs 434445561112
Operating Profit 10116109612111917
Operating Profit Margin (%) 30.2%31.9%18.1%23.7%23.1%17.8%26.7%17.3%16.7%14.5%
Other Income + 1110001112
Exceptional Items 0000000000
Interest 4455655656
Depreciation 3344445555
Profit Before Tax 44-310-331107
Tax 12-100-11032
Profit After Tax 33-110-22175
PAT Margin (%) 8.1%7.8%-4.3%1.8%0.2%-7.1%5.3%1.8%6.0%4.4%
Adjusted EPS (₹)3.22.9-1.30.70.1-2.22.01.05.44.1
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Valuation of Lactose India - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 20273134343439414752
Share Capital 9101010101113131313
Reserves 11172124242327283540
Debt +29283432364236333049
Long Term Debt23203432343934332426
Short Term Debt68002310624
Minority Interest0000000000
Trade Payables685542418811
Others Liabilities 29221211101011101521
Total Liabilities 83858382848890101101133

Fixed Assets

Net Fixed Assets +61626260625959565552
Gross Block84666971767881828588
Accumulated Depreciation233710141822263136
CWIP 11010400010
Investments 0110011000
Inventories6678987231725
Trade Receivables99577611121522
Cash Equivalents 0131232125
Others Assets 6444471091220
Total Assets 83858382848890101101133

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + 180572889-0
PBT 44-310-331107
Adjustment 679991010111010
Changes in Working Capital -8-3-5-4-2-4-4-4-10-16
Tax Paid -0-1-1-1000-0-1-1
Cash Flow From Investing Activity + 3-5-2-2-3-6-1-1-2-16
Capex -2-4-2-2-3-5-1-2-2-14
Net Investments 1-00-00-1010-0
Others 4-10000000-2
Cash Flow From Financing Activity + -5-34-5-45-8-8-619
Net Proceeds from Shares 0000032000
Net Proceeds from Borrowing -5-312-216-3-1-018
Interest Paid -4-4-6-5-6-5-5-6-5-5
Dividend Paid 0000000000
Others 44-2212-2-1-06
Net Cash Flow -0-03-211-0-113

Financial Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)15.6911.95-4.592.20.21-7.216.653.0315.4910.4
ROCE (%)14.7514.784.089.137.842.8110.219.2718.1813.01
Asset Turnover Ratio0.430.420.370.490.480.410.510.691.130.99
PAT to CFO Conversion(x)0.332.67N/A5N/AN/A481.29-0
Working Capital Days
Receivable Days75.1091.6083.9055.1063.107070.6066.1044.7058.10
Inventory Days42.8064.6079.8068.5077.6089.9061.3082.9063.4064.80
Payable Days289487.60428.20305.70288.90254165.10172.7095.8067.50

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *26.0626.0726.0726.0726.0726.0726.0726.0726.0726.07
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Lactose (India) Ltd FAQs

The current trading price of Lactose India on 04-Jun-2026 16:59 is ₹110.5.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of Lactose India stood at ₹139.1 Cr

The latest P/E ratio of Lactose India as of 03-Jun-2026 is 22.93.

The latest P/B ratio of Lactose India as of 03-Jun-2026 is 2.15.

The 52-week high of Lactose India is ₹136.7 and the 52-week low is ₹76.01.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Lactose India is ₹163 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Lactose (India) Ltd is a average quality company.

The key valuation ratios of Lactose (India) Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Lactose (India) Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Lactose (India) Ltd

Lactose (India), a Toshniwal Group company, was incorporated in 1991, under the Companies Act, 1956. Its  plant in Vadodara, Gujarat was commissioned by Alfa Laval, Pune (which is a subsidary of Alfa Laval of Sweden) and was also given a ‘thumbs up’ by reputed dairy experts from the Netherlands in October 1991. Subsequently Alfa Laval, reputed dairy experts from Sweden and a joint commission from the Netherlands studied the plant and its working and confidently acknowledged the plant for its quality standards as well.

For ten years now, Lactose (India) Limited has stood for perfection, quality, constant innovation and complete dedication to their clients. With up to date technology, the company is one of India's leading producers of Edible and Pharmaceutical grade Lactose. Apart from this, the company also manufactures Dairy Whitener, Dairy Calcium, Whey Powder, Casein, Caseinate, Butter and Ghee.

The company still boasts of being the first company to manufacture Lactose in the Asian subcontinent. The company has since grown to be a leading player in the Lactose market and continues to supply consistent quality Lactose to several global giants in the pharmaceutical world. It commands a 40% overall market share and this makes the company the leading Lactose supplier in the country.

With its unparalled infrastructure of requisite equipment and dedicated work force, Lactose (India) has a state of the art manufacturing facility for contract manufacturing of pharmaceutical products.The latest in its diverse interests is the manufacturing of pharmaceutical formulations for Aventis Pharma (earlier-Hoechst Marion Roussel), for the purpose of domestic use and export to Russia.

The state of art manufacturing facilities for the manufacture of pharmacuetical formulations is in compliance with all international standards.The plant is approved under WHO-cGMP guidelines and also holds TUV certificate as an ISO 9001 : 2000 company.The manufacturing facilities include wet granulation,Fluid bed drying, compaction, blending and coating facilities with the latest technology equipments.The manufacturing facilities is well supported by its total in-house Quality Control set-up with latest Testing equipments and an upto date Microbiology Testing Laboratory. The facility is supported by an equally competent and FDA approved Manufacturing professionals.

Besides providing lactose for pharmaceutical giants, food,confectionary and dairy companies in India, the company's product also leaves Indian shores for the African continent, South East Asia, and some of its other neighbouring countries.

After achieving its ambitious goal of being the most successful and leading Lactose manufacturer and supplier in the country, the company is now venturing aggressively into exports of pharmaceuticals and related products.

Product range of the company includes:

  • Edible and Pharmaceutical grade Lactose
  • Dairy Whitener
  • Dairy Calcium
  • Whey Powder
  • Casein
  • Caseinate
  • Butter and Ghee.

Awards & Achievements:

  • TUV Certificate
  • An ISO 9001:2000 Certified company
You have 0 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×